Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Integrin beta-2 inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lymphoma, Non-Hodgkin 1 D008228 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109346